 paracentesi intraven infus albumin peritoneoven cirrhosi refractori ascit background satisfactori treatment refractori ascit patient cirrhosi peritoneoven shunt paracentesi uncertainti rel merit method patient cirrhosi refractori ascit large-volum paracentesi intraven albumin leveen peritoneoven shunt patient paracentesi group recurr tens follow-up paracentesi peritoneovenous-shunt group diuret agent insert new shunt shunt obstruct result first hospit patient paracentesi group patient peritoneovenous-shunt group mean SD durat hospit group day signific differ number patient complic follow-up patient group paracentesi group number rehospit reason peritoneovenous-shunt group ascit median time first readmiss reason month ascit month peritoneovenous-shunt group total time hospit follow-up similar group day patient obstruct peritoneoven shunt first hospit patient total obstruct follow-up surviv similar group conclus leveen shunt paracentesi effect refractori ascit former long-term control ascit shunt occlus common surviv